- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00643656
Use of 50% Nitrous Oxide / 50% Oxygen Premix During Liver Biopsy of Focal Lesion
January 9, 2009 updated by: Air Liquide Santé International
Study of the Efficiency of Kalinox 170 Bar During Liver Biospy of Focal Lesion
A 50% nitrous oxide / 50% oxygen premix is administrated to the patient during the realization of liver biopsy in order to relax him and to reduce his pain during this painful medical treatment.
This single investigator centre and national clinical trial is done blindly : half of patients will receive 50% nitrous oxide / 50% oxygen premix and half of them a placebo gas (mixture of 50% oxygen and 50% nitrogen).
94 patients will be included in this clinical protocol.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
94
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Clichy, France, 92118
- Beaujon Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patient requiring a liver biopsy of focal lesion
- Age upper than 18 years
- OMS : 0 to 3
- patient consent form signed
Exclusion Criteria:
- patient unable to use Visual Analog Scale (VAS)
- OMS upper than 3
- coagulation disorder
- contraindication linked to the experimental product
- patient already included in another clinical trial uncompatible with this trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: A
Mixture of 50% nitrous oxide and 50% oxygen
|
Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour
|
PLACEBO_COMPARATOR: B
Mixture of 50% oxygen and 50% nitrogen
|
Flow of gas administrated to the patient between 4 and 15 litre/min and less than 1 hour
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Pain measurement by using Visual Analog Scale (VAS)
Time Frame: At the end of the liver biospy
|
At the end of the liver biospy
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patient's acceptance and doctor's satisfaction
Time Frame: At the end of the liver biopsy
|
At the end of the liver biopsy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Primary Completion (ACTUAL)
June 1, 2008
Study Completion (ACTUAL)
December 1, 2008
Study Registration Dates
First Submitted
March 19, 2008
First Submitted That Met QC Criteria
March 20, 2008
First Posted (ESTIMATE)
March 26, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
January 12, 2009
Last Update Submitted That Met QC Criteria
January 9, 2009
Last Verified
January 1, 2009
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EudraCT : 2006-004203-19
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Biopsy
-
Clear Guide MedicalNational Institutes of Health (NIH); Temple UniversityWithdrawnLiver Biopsy | Lung Biopsy | Kidney BiopsyUnited States
-
Yonsei UniversityRecruitingLiver Biopsy | Image-guided BiopsyKorea, Republic of
-
Mauna Kea TechnologiesCompletedLung Percutaneous Biopsy | Liver Percutaneous BiopsyFrance
-
AdventHealthWithdrawn
-
AdventHealthCompleted
-
Indiana UniversityTerminatedLiver BiopsyUnited States
-
University Hospital, Strasbourg, FranceTerminated
-
Mauna Kea TechnologiesCompletedLiver Percutaneous Biopsy or Ablation | Kidney Percutaneous Biopsy or AblationFrance
-
Seoul National University HospitalKorean Liver Cancer AssociationRecruitingContrast Media, Liver, Biopsy, FusionKorea, Republic of
-
University Hospital, Clermont-FerrandUnknownMRI | Hepatic Steatosis | Liver Biopsy | QuantificationFrance
Clinical Trials on Kalinox 170 bar
-
Air Liquide Santé InternationalCompleted
-
Air Liquide Santé InternationalWithdrawn
-
Air Liquide Santé InternationalCompleted
-
Institut de Cancérologie de LorraineCompletedCancer | BrachytherapyFrance
-
Curis, Inc.CompletedAdvanced Solid Tumors or LymphomasUnited States, Spain, Korea, Republic of, United Kingdom
-
Kansas State UniversityMGP Ingredients, Inc.WithdrawnOverweight or Obesity | Cholesterol, ElevatedUnited States
-
Aciex Therapeutics, Inc.CompletedAllergic ConjunctivitisUnited States
-
Toray Industries, IncCompletedCrohn's DiseaseBulgaria, France, Hungary, Belgium, Czech Republic, Latvia, Netherlands, Norway, Poland, Romania, Serbia, Sweden, Ukraine
-
Hannover Medical SchoolUnknown
-
Midwest Center for Metabolic and Cardiovascular...Ingredion IncorporatedCompletedBlood Glucose | Insulin Sensitivity | Dietary FiberUnited States